share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

輝瑞 | 4:持股變動聲明-董事 SMITH JAMES C
美股sec公告 ·  07/01 20:49
Moomoo AI 已提取核心訊息
In a recent transaction, James C. Smith, a reporting person for Pfizer Inc [PFE], executed a stock transaction on June 28, 2024. The details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The relationship of James C. Smith to Pfizer was not specified, and the current number of shares held by Smith after the transaction remains undisclosed.
In a recent transaction, James C. Smith, a reporting person for Pfizer Inc [PFE], executed a stock transaction on June 28, 2024. The details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The relationship of James C. Smith to Pfizer was not specified, and the current number of shares held by Smith after the transaction remains undisclosed.
最近,輝瑞報告人詹姆斯·C·史密斯(James C. Smith)於2024年6月28日進行了股票交易。 交易的詳細信息,包括交易股數、股票性質、交易價格和股票總價值,在公告中未予披露。詹姆斯·C·史密斯與輝瑞之間的關係未被指定,並且交易後史密斯持有的股票數量仍未公開。
最近,輝瑞報告人詹姆斯·C·史密斯(James C. Smith)於2024年6月28日進行了股票交易。 交易的詳細信息,包括交易股數、股票性質、交易價格和股票總價值,在公告中未予披露。詹姆斯·C·史密斯與輝瑞之間的關係未被指定,並且交易後史密斯持有的股票數量仍未公開。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息